We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+8.45%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$12.4B
AUM Growth
+$271M
(+2.2%)
Cap. Flow
-$478M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
289
New
32
Increased
64
Reduced
138
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$127M |
| 2 |
Gilead Sciences
GILD
|
+$125M |
| 3 |
PayPal
PYPL
|
+$89.3M |
| 4 |
UnitedHealth
UNH
|
+$88.1M |
| 5 |
GE Aerospace
GE
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$148M |
| 2 |
Kroger
KR
|
+$105M |
| 3 |
Costco
COST
|
+$94.8M |
| 4 |
Lam Research
LRCX
|
+$79.3M |
| 5 |
Charter Communications
CHTR
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.46% |
| 2 | Technology | 16.23% |
| 3 | Industrials | 15.74% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Baxter International
BAX
$14B
| $3.22M | 0.03% |
67,695
-1,044,915
| -94% | -$49.3M |
|
227
Verizon
VZ
$195B
| $1.94M | 0.02% |
37,325
-18,800
| -33% | -$1.01M |
|
228
National Health Investors
NHI
$3.65B
| $1.51M | 0.01% |
19,230
-109,945
| -85% | -$8.65M |
|
229
Walt Disney
DIS
$182B
| $1.4M | 0.01% |
15,030
-360
| -2% | -$34.5K |
|
230
Adtran
ADTN
$611M
| $1.25M | 0.01% |
65,540
-285,375
| -81% | -$5.26M |
|
|
WCN
231
Waste Connections
WCN
$42.2B
| $1.09M | 0.01% |
21,938
-23,620
| -52% | -$1.19M |
|
232
Kirby Corp
KEX
$7.11B
| $1.03M | 0.01% |
16,590
-318,115
| -95% | -$18.3M |
|
|
233
Costco
COST
$421B
| $941K | 0.01% |
6,170
-586,915
| -99% | -$94.8M |
|
234
CVS Health
CVS
$123B
| $854K | 0.01% |
9,600
-7,700
| -45% | -$727K |
|
235
Northern Trust
NTRS
$33.7B
| $822K | 0.01% |
12,096
| – | – |
|
236
Merck
MRK
$317B
| $759K | 0.01% |
12,743
| – | – |
|
237
SLB Ltd
SLB
$76.5B
| $662K | 0.01% |
8,424
| – | – |
|
238
3M
MMM
$93.2B
| $626K | 0.01% |
4,246
-6,937
| -62% | -$1.04M |
|
239
ExxonMobil
XOM
$642B
| $492K | ﹤0.01% |
5,640
-728
| -11% | -$64.6K |
|
240
CSX Corp
CSX
$93.9B
| $458K | ﹤0.01% |
45,000
| – | – |
|
241
Lindblad Expeditions
LIND
$2.23B
| $457K | ﹤0.01% |
50,800
| – | – |
|
|
TDAY
242
USA Today Co
TDAY
$1.17B
| $333K | ﹤0.01% |
21,500
| – | – |
|
243
Ventas
VTR
$47.3B
| $333K | ﹤0.01% |
4,719
| – | – |
|
244
Campbell Soup
CPB
$6.73B
| $328K | ﹤0.01% |
6,000
| – | – |
|
245
IBM
IBM
$220B
| $318K | ﹤0.01% |
2,092
| – | – |
|
|
KA
246
DELISTED
Kineta, Inc. Common Stock
KA
| $307K | ﹤0.01% |
+141
| New | +$262K |
|
247
State Street
STT
$50.8B
| $267K | ﹤0.01% |
3,840
| – | – |
|
248
Mondelez International
MDLZ
$80.1B
| $263K | ﹤0.01% |
6,000
-1,500
| -20% | -$65.8K |
|
249
Medtronic
MDT
$110B
| $214K | ﹤0.01% |
2,478
-500
| -17% | -$43.6K |
|
250
Aptiv
APTV
$9.61B
| – | – |
-269,020
| Closed | -$16.8M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Westfield Capital Management held 289 positions worth $12.4B, up 2.2% from $12.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $478M in Q3 2016, closing 40 positions and reducing 138 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $148M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
Against the trend, Westfield Capital Management opened a new position in Abbott worth $126M.
- Westfield Capital Management's largest Q3 2016 buy was Abbott: 2,973,638 shares worth $126M.
- Westfield Capital Management added most to UnitedHealth in Q3 2016, an estimated $88.1M increase.
- Westfield Capital Management's biggest Q3 2016 reduction was Costco, cutting an estimated $94.8M.
- Westfield Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $148M.
- Westfield Capital Management's ten largest holdings make up 17% of its $12.4B portfolio in Q3 2016.
- Westfield Capital Management opened 32 new positions and closed 40 in Q3 2016.
- Westfield Capital Management's portfolio value rose 2.2% quarter-over-quarter to $12.4B.
Based on Westfield Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.